Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C16H18N2O2 |
| Molecular Weight | 270.3263 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(=CC=C1)C#CCO\N=C2/C[N@]3CC[C@@H]2C3
InChI
InChIKey=FXBXWJPMXQHOGD-UVTIVQHFSA-N
InChI=1S/C16H18N2O2/c1-19-15-6-2-4-13(10-15)5-3-9-20-17-16-12-18-8-7-14(16)11-18/h2,4,6,10,14H,7-9,11-12H2,1H3/b17-16+/t14-/m1/s1
| Molecular Formula | C16H18N2O2 |
| Molecular Weight | 270.3263 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 1 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Tue Apr 01 16:25:31 GMT 2025
by
admin
on
Tue Apr 01 16:25:31 GMT 2025
|
| Record UNII |
2A2XC2CE1G
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
149929-39-5
Created by
admin on Tue Apr 01 16:25:31 GMT 2025 , Edited by admin on Tue Apr 01 16:25:31 GMT 2025
|
PRIMARY | |||
|
2A2XC2CE1G
Created by
admin on Tue Apr 01 16:25:31 GMT 2025 , Edited by admin on Tue Apr 01 16:25:31 GMT 2025
|
PRIMARY | |||
|
PD-151832
Created by
admin on Tue Apr 01 16:25:31 GMT 2025 , Edited by admin on Tue Apr 01 16:25:31 GMT 2025
|
PRIMARY | PD 151832, a potent and selective muscarinic M1 receptor agonist, has shown promise as a cognition enhancing agent. PD 151832 was undergoing preclinical. | ||
|
9795428
Created by
admin on Tue Apr 01 16:25:31 GMT 2025 , Edited by admin on Tue Apr 01 16:25:31 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
